Poor glycemic control is a significant predictor of cardiovascular events in chronic hemodialysis patients with diabetes

Therapeutic Apheresis and Dialysis

Volumn 13, Issue 4, 2009, Pages 358-365

  Tsujimoto, Yoshihiro ^a   Ishimura, Eiji ^b   Tahara, Hideki ^c   Kakiya, Ryuusuke ^a   Koyama, Hidenori ^c   Emoto, Masanori ^c   Shoji, Tetsuo ^c   Inaba, Masaaki ^c   Kishimoto, Hiroshi ^a   Tabata, Tsutomu ^a   Nishizawa, Yoshiki ^c  

^a Inoue Hospital   (Japan)

^b Department of Nephrology ^*  (Japan)

^c OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Arterio occlusive disease; Cardiovascular events; Diabetes; Fatal and non fatal events; Hemodialysis; Hemoglobin A1C

Indexed keywords

HEMOGLOBIN A1C; INSULIN; ORAL ANTIDIABETIC AGENT;

ADULT; AGED; ARTERIOSCLEROSIS; BRAIN HEMORRHAGE; BRAIN INFARCTION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC PATIENT; FEMALE; FOLLOW UP; GLYCEMIC CONTROL; HAZARD RATIO; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; ISCHEMIC HEART DISEASE; KAPLAN MEIER METHOD; LONGITUDINAL STUDY; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; TREATMENT DURATION;

ADULT; AGED; AGED, 80 AND OVER; BLOOD GLUCOSE; CARDIOVASCULAR DISEASES; COHORT STUDIES; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FEMALE; FOLLOW-UP STUDIES; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; KAPLAN-MEIER ESTIMATE; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RENAL DIALYSIS;

EID: 68849096435     PISSN: 17449979     EISSN: 17449987     Source Type: Journal    
DOI: 10.1111/j.1744-9987.2009.00691.x     Document Type: Conference Paper

References (30)

1. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993 329 : 977 86.
2. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998 352 : 837 53.
3. Chiasson JL, Josse RG, Gomis R et al. Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial. JAMA 2003 290 : 486 94.
4. Gaede P, Vedel P, Larsen N et al. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med 2003 348 : 383 93.
5. Wu MS, Yu CC, Yang CW et al. Poor pre-dialysis glycaemic control is a predictor of mortality in type II diabetic patients on maintenance haemodialysis. Nephrol Dial Transplant 1997 12 : 2105 10.
6. Morioka T, Emoto M, Tabata T et al. Glycemic control is a predictor of survival for diabetic patients on hemodialysis. Diabetes Care 2001 24 : 909 13.
7. Okada T, Nakao T, Matsumot H. Predialysis factors related to prognosis in type 2 diabetic patients on chronic dialysis in Japan. Nephrology (Carlton) 2002 7 : 250 6.
8. Oomichi T, Emoto M, Tabata T et al. Impact of glycemic control on survival of diabetic patients on chronic regular hemodialysis: a 7-year observational study. Diabetes Care 2006 29 : 1496 500.
9. Fukuoka K, Nakao K, Morimoto H et al. Glycated albumin levels predict long-term survival in diabetic patients undergoing haemodialysis. Nephrology (Carlton) 2008 13 : 278 83.
10. Okada T, Nakao T, Matsumoto H et al. Association between markers of glycemic control, cardiovascular complications and survival in type 2 diabetic patients with end-stage renal disease. Intern Med 2007 46 : 807 14.
11. Williams ME, Lacson E Jr., Teng M et al. Hemodialyzed type I and type II diabetic patients in the US: characteristics, glycemic control, and survival. Kidney Int 2006 70 : 1503 9.
12. Kalantar-Zadeh K, Kopple JD, Regidor DL et al. A1C and survival in maintenance hemodialysis patients. Diabetes Care 2007 30 : 1049 55.
13. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997 20 : 1183 97.
14. Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic criteria. The DECODE Study Group. European Diabetes Epidemiology Group. Diabetes epidemiology: collaborative analysis of diagnostic criteria in Europe. Lancet 1999 354 : 617 21.
15. Khaw KT, Wareham N, Bingham S et al. Association of hemoglobin A1c with cardiovascular disease and mortality in adults: the European prospective investigation into cancer in Norfolk. Ann Intern Med 2004 141 : 413 20.
16. Selvin E, Coresh J, Golden SH et al. Glycemic control and coronary heart disease risk in persons with and without diabetes: the atherosclerosis risk in communities study. Arch Intern Med 2005 165 : 1910 16.
17. Stratton IM, Adler AI, Neil HA et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 2000 321 : 405 12.
18. Tanaka Y, Atsumi Y, Matsuoka K et al. Role of glycemic control and blood pressure in the development and progression of nephropathy in elderly Japanese NIDDM patients. Diabetes Care 1998 21 : 116 20.
19. Testa MA, Simonson DC, Turner RR. Valuing quality of life and improvements in glycemic control in people with type 2 diabetes. Diabetes Care 1998 21 (Suppl. 3 C44 52.
20. Friedman EA. Advanced glycation end-products in diabetic nephropathy. Nephrol Dial Transplant 1999 14 (Suppl. 3 1 9.
21. Goldstein DE, Little RR, Lorenz RA et al. Tests of glycemia in diabetes. Diabetes Care 2004 27 : 1761 73.
22. Little RR, Tennill AL, Rohlfing C et al. Can glycohemoglobin be used to assess glycemic control in patients with chronic renal failure? Clin Chem 2002 48 : 784 6.
23. Inaba M, Okuno S, Kumeda Y et al. Glycated albumin is a better glycemic indicator than glycated hemoglobin values in hemodialysis patients with diabetes: effect of anemia and erythropoietin injection. J Am Soc Nephrol 2007 18 : 896 903.
24. Taniwaki H, Kawagishi T, Emoto M et al. Correlation between the intima-media thickness of the carotid artery and aortic pulse-wave velocity in patients with type 2 diabetes. Vessel wall properties in type 2 diabetes. Diabetes Care 1999 22 : 1851 7.
25. Taniwaki H, Shoji T, Emoto M et al. Femoral artery wall thickness and stiffness in evaluation of peripheral vascular disease in type 2 diabetes mellitus. Atherosclerosis 2001 158 : 207 14.
26. Yokoyama H, Aoki T, Imahori M et al. Subclinical atherosclerosis is increased in type 2 diabetic patients with microalbuminuria evaluated by intima-media thickness and pulse wave velocity. Kidney Int 2004 66 : 448 54.
27. Fujishima M, Kiyohara Y, Kato I et al. Diabetes and cardiovascular disease in a prospective population survey in Japan: the Hisayama Study. Diabetes 1996 45 (Suppl. 3 S14 16.
28. Iseki K, Fukiyama K. Clinical demographics and long-term prognosis after stroke in patients on chronic haemodialysis. The Okinawa Dialysis Study (OKIDS) Group. Nephrol Dial Transplant 2000 15 : 1808 13.
29. Kuroda K, Kuwata N, Sato N et al. Changes in cerebral blood flow accompanied with reduction of blood pressure treatment in patients with hypertensive intracerebral hemorrhages. Neurol Res 1997 19 : 169 73.
30. Kuwata N, Kuroda K, Funayama M et al. Dysautoregulation in patients with hypertensive intracerebral hemorrhage. A SPECT study. Neurosurg Rev 1995 18 : 237 45.